维普期刊资源整合服务平台（V6.5）

33篇 您的检索式：作者名="LOZANSKI G"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	The CD4+lymphopenic sarcoidosis phenotype is highly responsive to anti-tumor necrosis factor-{alpha}therapy显示文摘	Crouser ED Lozanski G Fox CC	2010	Chest2010，137，6：	1
2	Higher doses of lenalidomide are associated with unacceptable toxicity including life-threatening tumor flare in patients with chronic lymphocytic leukemia 显示文摘	Andritsos L A Johnson A J Lozanski G	2008	Journal of Clinical Oncology2008，26，15：	1
3	Induction of inflammatory cytokine release from cultured human monocytes by C- reactive protein显示文摘	Ballou SP Lozanski G	1992	Cytokine1992，4，：	1
4	Adult Burkitt leukemia and lymphoma显示文摘	BLUM K A LOZANSKI G BYRD J C	2004	Blood2004，104，：	1
5	Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein 显示文摘	Ballou SP Lozanski G	1992	Cytokine1992，4，5：	1
6	Adult Burkitt leukemia and lymphoma显示文摘	Blum KA Lozanski G Byrd JC	2004	Blood2004，104，10：	1
7	Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein显示文摘	Ballou SP Lozanski G	1992	Cytokine1992，4，：	1
8	The sphingomyelin-ceramide pathway participates in cytokine regulation of C-reactive protein and serum amyloid butnot -fibrinogen显示文摘	Lozanski G Berthier F Kushner I	1997	Siochem J1997，328，1：	1
9	Induction of inflammatory cytokine release from cultured human monocytes by Creactive protein 显示文摘	Ballou SP Lozanski G	1992	Cytokine1992，4，：	1
10	Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein显示文摘	Ballou SP Lozanski G	1992	Cytokine1992，4，：	1
11	Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions显示文摘	Lozanski G Heerema NA Flinn IW	2004	Blood2004，103，9：	1
12	Alemtuzumab can be Incorporated Into Front-Line Therapy of Adult Acute Lymphoblastic Leukemia(ALL): Final Phase 1 Results of a Cancer and Leukemia Group B Study (CALGBI0102) 显示文摘	Stock W Sanford B Lozanski G	2009	Blood2009，114，：	1
13	Adult Burkitt leukemia and lymphoma显示文摘	Blum KA Lozanski G Byrd JC	2004	Blood2004，104，10：	1
14	Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions显示文摘	Lozanski G Heerema NA Flinn IW	2004	Blood2004，103，9：	1
15	Induction of inflammatory eytokine release from cultured human monocytes by C-reactive protein显示文摘	Ballou SP Lozanski G	1992	Cytokine1992，4，5：	1
16	Adult Burkitt leukemia and lymphoma显示文摘	Blum KA Lozanski G Byrd JC	2004	Blood2004，104，10：	1
17	Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein显示文摘	Ballou SP Lozanski G	1992	Cytokine1992，4，5：	1
18	Alemtuzumab is an Effective Therapy for Chronic Lymphocytic Leukemia with p53 Mutations and Deletions显示文摘	Lozanski G Heerema NA	2004	Blood2004，103，：	1
19	Alemtu-zumab is an effective therapy for chronic lymphocyticleukemia with p53 mutations and deletions 显示文摘	LOZANSKI G HEEREMA N’FLINN I	2004	Blood2004，103，：	1
20	Adult Burkitt leukemia and lymphoma显示文摘	Blum KA Lozanski G Byrd JC	2004	Blood2004，104，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示